April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Wide-field Fundus Autofluorescence Abnormalities and Visual Function in Patients with Cone-dominant Hereditary Retinal Dystrophy
Author Affiliations & Notes
  • Maho Oishi
    Kyoto University, Kyoto, Japan
  • Akio Oishi
    Kyoto University, Kyoto, Japan
  • Ken Ogino
    Kyoto University, Kyoto, Japan
  • Yukiko Makiyama
    Kyoto University, Kyoto, Japan
  • Norimoto Gotoh
    Kyoto University, Kyoto, Japan
  • Masafumi Kurimoto
    Kyoto University, Kyoto, Japan
  • Nagahisa Yoshimura
    Kyoto University, Kyoto, Japan
  • Footnotes
    Commercial Relationships Maho Oishi, None; Akio Oishi, None; Ken Ogino, None; Yukiko Makiyama, None; Norimoto Gotoh, None; Masafumi Kurimoto, None; Nagahisa Yoshimura, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2624. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maho Oishi, Akio Oishi, Ken Ogino, Yukiko Makiyama, Norimoto Gotoh, Masafumi Kurimoto, Nagahisa Yoshimura; Wide-field Fundus Autofluorescence Abnormalities and Visual Function in Patients with Cone-dominant Hereditary Retinal Dystrophy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2624. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Fundus autofluorescence (FAF) imaging is a noninvasive modality that allows evaluating the status of photoreceptor cells and the retinal pigment epithelium. Here we examined wide-field FAF images of patients with cone-dominant hereditary retinal dystrophies and evaluate the clinical utility of the device.

Methods: We evaluated the right eyes of 37 patients with cone rod dystrophy (CRD), 12 patients with cone dystrophy (CD), and 26 patients with macular dystrophy (MD). MD includes 6 patients with central areolar choroidal dystrophy (CACD) and 15 patients with Stargardt’s disease (STGD). The eyes were divided into three groups based on the area of abnormal FAF. Those patients with abnormal FAF confined to an elliptically shaped central area of 1000 × 700 pixels as measured with ImageJ software® were considered as Type 1, those with abnormal FAF confined to an area of 2000 × 1400 pixels were considered as Type 2, and those with peripheral abnormal FAF were considered as Type 3. The results of visual acuity measurements, kinetic perimetry, and electroretinography (ERG) were compared among the groups.

Results: There was no significant difference in general patient characteristics among the three groups. The ERG amplitudes recorded under all conditions were smaller among Type 3 patients. The mean amplitude of b-waves measured using dark-adapted 3.0 ERG was 76.4 ± 59.4 µV for Type 3, which is smaller than that measured for type 1 (224.8 ± 90.2, P < 0.001) and type 2 (188.6 ± 72.5, P < 0.001). In addition, type 3 patients showed worse visual acuity (1.04 ± 0.64 logMAR units) than type 1 (0.59 ± 0.55 logMAR units, P = 0.012) and had scotomas of larger area (30.8 ± 18.0 cm2) than type 1 (5.7 ± 5.5 cm2, P < 0.001) and type 2 patients (14.8 ± 11.9 cm2, P = 0.016). The mean amplitude of b-waves measured using dark-adapted 0.01 ERG and scotoma area differed significantly between Type 1 and Type 2.

Conclusions: The extent of abnormal FAF reflects the functional impairment in patients with cone-dominant retinal dystrophies. FAF measurements are useful for assessing retinal function in these patients.

Keywords: 696 retinal degenerations: hereditary • 550 imaging/image analysis: clinical • 758 visual fields  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.